Business

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical

articleNeuroone Medical Technologies CorporationNovember 13, 20244/company/neuroone-medical-technologies-corp/news/neuroone-medical-technologies-corporation-to-present-at-november-21st-virtual-investor-summit-microcap-event
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

About this update from Neuroone Medical Technologies Corporation

[{"type":"text","content":"EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) (\"NeuroOne\" or the \"Company\"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.Event: Q4 Investor SummitDate: Thursday, November 21, 2024Presentation Time: 1:30pm - 2:00pm ETLocation: https://www.webcaster4.com/Webcast/Page/3075/51590The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.Take a deep dive with the best Investors in MicroCapLive Q & AComplimentary to Qualified Investors. Please REGISTER HERE.About the Investor SummitThe Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.About NeuroOneNeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.Contact:Fred [email protected] Summit GroupNMTC IR ContactQuinn Callanan, CFA or Brian Prenoveau, CFAMZ Group - MZ North [email protected](949) 694-9594SOURCE: NeuroOne Medical Technologies CorporationView the original press release on accesswire.com","length":3427,"tagName":"div"}]

More updates from Neuroone Medical Technologies Corporation